Atlas Venture, a prominent venture capital firm in the biotech industry, has raised $450 million for its 14th fund. The fund will focus on seed and series A rounds for biotech companies, with Atlas often playing a role in creating these companies. Unlike other firms, Atlas does not usually accept pitches from outside entrepreneurs, but will collaborate with other VC firms on new startups. The news of the fund comes shortly after Partner Bruce Booth mentioned it during a recent presentation. This development signals Atlas Venture’s continued commitment to supporting and nurturing innovative biotech startups.
Source link
Atlas Venture raises $450 million fund
